61 related articles for article (PubMed ID: 32642498)
1. Quma Tongluo Prescription in the Treatment of Chronic Oxaliplatin Related Peripheral Neuropathy: A Single-Center, Open, Randomized Controlled Study.
Jia J; Yang Y; Shi C; Du M; Tang Y; Yin X; Hou F
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38551443
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced Acute Neurotoxicity Recovers Between Repeat Infusion Cycles: An Axonal Excitability Repeated Multiple Measurements Study.
Kokotis P; Papantoniou M; Carr RW; Schmelz M; Siakavella D; Skafida E; Papadimitriou C
Cancer Diagn Progn; 2024; 4(3):320-325. PubMed ID: 38707730
[TBL] [Abstract][Full Text] [Related]
3. Self-management of oxaliplatin-related peripheral neuropathy in colorectal cancer survivors.
Tofthagen C; Gonzalez L; Visovsky C; Akers A
Chemother Res Pract; 2013; 2013():547932. PubMed ID: 24062949
[TBL] [Abstract][Full Text] [Related]
4. MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review.
Isaac MFG; Alkhatib R; Ho CL
Insights Imaging; 2024 Jan; 15(1):12. PubMed ID: 38228948
[TBL] [Abstract][Full Text] [Related]
5. Atypical neurological toxicity attributed to oxaliplatin.
Daly W; Lakhoua G; Zaiem A; Charfi O; Kastalli S; Daghfous R; El Aidli S
Therapie; 2023; 78(4):451-453. PubMed ID: 36243588
[No Abstract] [Full Text] [Related]
6. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
Yokoyama S; Nakagawa C; Hosomi K
Support Care Cancer; 2022 Feb; 30(2):1765-1773. PubMed ID: 34595605
[TBL] [Abstract][Full Text] [Related]
7. Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN).
Argyriou AA
Toxics; 2015 May; 3(2):187-197. PubMed ID: 29056657
[TBL] [Abstract][Full Text] [Related]
8. Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity.
Velasco R; Alemany M; Villagrán M; Argyriou AA
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357136
[TBL] [Abstract][Full Text] [Related]
9. The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey.
Ali NT; Mohamed AA; Yousef BA
Asia Pac J Oncol Nurs; 2020; 7(3):266-272. PubMed ID: 32642498
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced Peripheral Neuropathy in South Indian Cancer Patients: A Prospective Study in Digestive Tract Cancer Patients.
Palugulla S; Dkhar SA; Kayal S; Narayan SK
Indian J Med Paediatr Oncol; 2017; 38(4):502-507. PubMed ID: 29333020
[TBL] [Abstract][Full Text] [Related]
11. Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
Argyriou AA; Cavaletti G; Antonacopoulou A; Genazzani AA; Briani C; Bruna J; Terrazzino S; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Psaromyalou A; Angelopoulou A; Kalofonos HP
Cancer; 2013 Oct; 119(19):3570-7. PubMed ID: 23821303
[TBL] [Abstract][Full Text] [Related]
12. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
[TBL] [Abstract][Full Text] [Related]
13. Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.
Hsu SY; Huang WS; Lee SH; Chu TP; Lin YC; Lu CH; Beaton RD; Jane SW
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12976. PubMed ID: 30536809
[TBL] [Abstract][Full Text] [Related]
14. Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.
Argyriou AA; Kalofonou F; Litsardopoulos P; Anastopoulou GG; Psimaras D; Bruna J; Kalofonos HP
J Peripher Nerv Syst; 2020 Jun; 25(2):178-183. PubMed ID: 32277545
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
